Humacyte, Inc.

HUMA · Healthcare

$0.57

Capitalizzazione: 158.46M USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Humacyte, Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

GlobeNewswire3 set 2026, 14:11

Decentralized Clinical Trial Technology Platform Market to Reach $6.12 Billion by 2030 as Virtual Research Adoption Accelerates

GlobeNewswire27 ago 2026, 17:00

Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsight

The Wall Street Journal26 ago 2026, 23:00

Hakeem Jeffries Confronts Left-Wing Backlash to Jared Kushner Meeting

GlobeNewswire25 ago 2026, 13:00

AI in Patient Engagement Market Size to Reach USD 45.90 Billion by 2035 as Healthcare Automation Accelerates – SNS Insider

MT Newswires24 ago 2026, 12:53

Humacyte Plans FDA Filing for Acellular Tissue Engineered Vessel in Dialysis Access